Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
J&J Worldwide Pharma Chairman Joaquin Duato's Interview with China Daily: Serving in the Name of Progress(9/13/2017 )  (Premium)
Editor´s Picks
Anti-monopoly Enforcement Trends in China's Healthcare Industry(9/13/2017 )  (Premium)
China Liberalises Policy on Medical Institutions(9/13/2017 )  (Premium)
Regulatory Changes Position China as a Global Clinical Trial Destination(9/11/2017 )  (Premium)
The Market
QuintilesIMS: Chinese Retail Pharmacy Sales Up 1. 4% in MAT Q2/2017(9/12/2017 )  (Premium)
QuintilesIMS: Chinese Hospital Drug Sales Up 6.3% in Q2/2017(9/12/2017 )  (Premium)
Industry News
Eyeing Potential Baby Boom, Aspen Pharma Plans China Expansion(9/15/2017 )  (Premium)
Recent Executive Moves(9/14/2017 )  (Premium)
Hanall Biopharma, HarbourBIoMed in Licensing Deal for China Rights of Two Biologicals(9/13/2017 )  (Premium)
Shire Reveals Ambition to Fight Rare Diseases in China during GT Interview(9/11/2017 )  (Premium)
China to Complete Establishment of National Rare Disease Registry by 2020(9/11/2017 )  (Premium)
HitGen and Takeda Enter DNA-Encoded Library Based Drug Discovery Research Collaboration(9/11/2017 )  (Premium)
Regulatory News
CFDA Solicits Comments on Draft Announcement for Amendment of Drug Registration Acceptance Process(9/13/2017 )  (Premium)
CFDA Issues New Announcement (2017#109) for Clinical Data Self-Inspection(9/13/2017 )  (Premium)
CFDA Issues Technical Guidelines for TCM Post Marketing Production Process Changes(9/11/2017 )  (Premium)
General Health
China Sees Rising Incidence of Breast Cancer in Recent Years(9/15/2017 )  (Premium)
China Sets Up The Changing Diabetes Foundation with Help of Novo Nordisk(9/14/2017 )  (free)
NHFPC Releases 2016 Annual Health and Family Planning Sector Development Report (Full Summary)(9/14/2017 )  (Premium)
NHFPC and SATCM Issue Guiding Principles for Clinical Pathway Management of Medical Institutions(9/14/2017 )  (Premium)
Product/R&D News
Galectin Therapeutics To Be Granted Chinese Patent for Its Lead Cirrhosis/Fibrosis Compound(9/13/2017 )  (Premium)
BeiGene Presents Preliminary Phase 1 Data for BGB-A317 in Multiple Solid Tumors at ESMO 2017(9/11/2017 )  (Premium)
Other News
Hays Poll: Job Seekers in China Prefer Personal Networking over Social Media for New Jobs(9/11/2017 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links